Brain Cancer
Oncology·MeSH: Brain Neoplasms
8 drugs in development·7 companies·7 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Voranigo | Royalty Pharma plc (RPRX) |
Phase 2(1)
| Drug | Company |
|---|---|
| reyobiq | PLUS THERAPEUTICS Inc. (PSTV) |
Phase 1(1)
| Drug | Company |
|---|---|
| pritumumab | Nascent Biotech Inc. (NBIO) |
Preclinical(4)
BLA Filed(1)
| Drug | Company |
|---|---|
| dcvax-l | NORTHWEST BIOTHERAPEUTICS INC (NWBO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Brain Cancer?
BioSniper tracks 8 drugs in development for Brain Cancer across 7 companies.
How many clinical trials target Brain Cancer?
There are 7 clinical trials targeting Brain Cancer tracked by BioSniper.
Deep-dive into Brain Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis